[Hemosorption in the combined treatment of patients with ischemic heart disease and diabetes mellitus].
Extracorporal hemosorption was carried out in 42 patients with diabetes mellitus and ischemic heart disease and a positive effort was observed. This was manifested in a reduction of the clinical manifestations of ischemic heart disease: decrease of the frequency, duration and intensity of stenocardia attacks, 2.5 times reduction on necessity in coronarolytic agents. Hemosorption was effective in the control of arrhythmia and disorders of cardiac conduction. The postsorption period was characterized by stabilization of diabetes mellitus reduction of diurnal fluctuations of glycemia and glucosuria, decrease of peroral sugar-reducing agents.
Trusov
V V
VV
Zhuplatov
S B
SB
Chernyshova
T E
TE
Marizin
S A
SA
Kats
I M
IM
D000328:Adult; D001161:Arteriosclerosis / Q000150:complications / Q000503:physiopathology / Q000628:therapy; D002908:Chronic Disease; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D003920:Diabetes Mellitus / Q000503:physiopathology / Q000628:therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D008297:Male; D008875:Middle Aged
Gemosorbtsiia v kompleksnom lechenii bol'nykh ishemicheskoĭ bolezn'iu serdtsa i sakharnym diabetom.